CHARACTERIZATION OF THE CYSTEINE-RICH REGION OF THE CAENORHABDITIS-ELEGANS PROTEIN UNC-13 AS A HIGH-AFFINITY PHORBOL ESTER RECEPTOR - ANALYSIS OF LIGAND-BINDING INTERACTIONS, LIPID COFACTOR REQUIREMENTS, AND INHIBITOR SENSITIVITY
Mg. Kazanietz et al., CHARACTERIZATION OF THE CYSTEINE-RICH REGION OF THE CAENORHABDITIS-ELEGANS PROTEIN UNC-13 AS A HIGH-AFFINITY PHORBOL ESTER RECEPTOR - ANALYSIS OF LIGAND-BINDING INTERACTIONS, LIPID COFACTOR REQUIREMENTS, AND INHIBITOR SENSITIVITY, The Journal of biological chemistry, 270(18), 1995, pp. 10777-10783
The Caenorhabditis elegans Unc-13 protein is a novel member of the pho
rbol ester receptor family having a single cysteine-rich region with h
igh homology to those present in protein kinase C (PKC) isozymes and t
he chimaerins, We expressed the cysteine-rich region of Unc-13 in Esch
erichia coli and quantitatively analyzed its interactions with phorbol
esters and related analogs, its phospholipid requirements, and its in
hibitor sensitivity, [H-3]Phorbol 12,13-dibutyrate [H-3]PDBu bound wit
h high affinity to the cysteine-rich region of Unc-13 (K-d = 1.3 +/- 0
.2 nM). This affinity is similar to that of other single cysteine-rich
regions from PKC isozymes as well as n-chimaerin, As also described f
or PKC isozymes and n-chimaerin, Unc-13 bound diacylglycerol with an a
ffinity about 2 orders of magnitude weaker than [H-3]PDBu. Structure a
ctivity analysis revealed significant but modest differences between r
ecombinant cysteine-rich regions of Unc-13 and PKC delta. In addition,
Unc-13 required slightly higher concentrations of phospholipid for re
constitution of [H-3]PDBu binding. Calphostin C, a compound described
as a selective inhibitor of PKC, was also able to inhibit [H-3]PDBu bi
nding to Unc-13, suggesting that this inhibitor is not able to disting
uish between different classes of phorbol ester receptors, In conclusi
on, although our results revealed some differences in ligand and lipid
cofactor sensitivities, Unc-13 represents a high affinity cellular ta
rget for the phorbol esters as well as for the lipid second messenger
diacylglycerol, at least in C. elegans, The use of phorbol esters or s
ome ''specific'' antagonists of PKC does not distinguish between cellu
lar pathways involving different PKC isozymes or novel phorbol ester r
eceptors such as n-chimaerin or Unc-13.